Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses
Authors
Keywords
-
Journal
Viruses-Basel
Volume 10, Issue 1, Pages 48
Publisher
MDPI AG
Online
2018-01-22
DOI
10.3390/v10010048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chasing Seasonal Influenza — The Need for a Universal Influenza Vaccine
- (2018) Catharine I. Paules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Promising approaches for the treatment and prevention of viral respiratory illnesses
- (2017) Nikolaos G. Papadopoulos et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- ICTV Virus Taxonomy Profile: Pneumoviridae
- (2017) Bert Rima et al. JOURNAL OF GENERAL VIROLOGY
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
- (2017) Ting Shi et al. LANCET
- In vitro evaluation of Selective Inhibitors of Nuclear Export (SINE) drugs KPT-185 and KPT-335 against canine mammary carcinoma and transitional cell carcinoma tumor initiating cells
- (2017) J. E. Grayton et al. Veterinary and Comparative Oncology
- Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development
- (2017) Nopporn Chutiwitoonchai et al. VIROLOGY
- Ongoing developments in RSV prophylaxis: a clinician’s analysis
- (2017) Fariba Rezaee et al. Current Opinion in Virology
- CRM1 Inhibitors for Antiviral Therapy
- (2017) Cynthia Mathew et al. Frontiers in Microbiology
- Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
- (2017) Louis Fries et al. Immunity & Ageing
- Respiratory syncytial virus: prospects for new and emerging therapeutics
- (2017) Patricia A. Jorquera et al. Expert Review of Respiratory Medicine
- Recent Advances in Developing Antiviral Therapies for Respiratory Syncytial Virus
- (2017) Brian C. Shook et al. Topics in Current Chemistry
- Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone
- (2016) Irfana Muqbil et al. CANCER LETTERS
- The inflammatory response triggered by Influenza virus: a two edged sword
- (2016) Luciana P. Tavares et al. INFLAMMATION RESEARCH
- ALS-008176 for Respiratory Syncytial Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection
- (2016) Olivia Perwitasari et al. PLoS One
- Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
- (2016) Wenqian He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The host immune response in respiratory virus infection: balancing virus clearance and immunopathology
- (2016) Amy H. Newton et al. Seminars in Immunopathology
- Structural Characterization of H1N1 Nucleoprotein-Nucleozin Binding Sites
- (2016) Bo Pang et al. Scientific Reports
- Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
- (2016) Malak M. Alame et al. Frontiers in Microbiology
- Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies
- (2015) K. L. Berger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein
- (2015) Dharmaraj Samuel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process
- (2015) Michel Perron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen
- (2015) Valerie A. Laganas et al. ANTIVIRAL RESEARCH
- Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors
- (2015) Michael J. Boyd et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study
- (2015) Richard L. Mackman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter
- (2015) Sarah L. Noton et al. JOURNAL OF VIROLOGY
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
- (2015) John P. DeVincenzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Respiratory Syncytial Virus Nonstructural Proteins Upregulate SOCS1 and SOCS3 in the Different Manner from Endogenous IFN Signaling
- (2015) Junwen Zheng et al. Journal of Immunology Research
- Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics
- (2015) Natalie I Mazur et al. Lancet Respiratory Medicine
- Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs
- (2015) Irene Ramos et al. Frontiers in Immunology
- Structural Basis of Targeting the Exportin CRM1 in Cancer
- (2015) Achim Dickmanns et al. Cells
- Characterization of Drug-Resistant Influenza Virus A(H1N1) and A(H3N2) Variants SelectedIn Vitrowith Laninamivir
- (2014) Mélanie Samson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit
- (2014) Randal A. Byrn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action for Respiratory Syncytial Virus Inhibitor RSV604
- (2014) SreeRupa Challa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nitazoxanide: A first-in-class broad-spectrum antiviral agent
- (2014) Jean-François Rossignol ANTIVIRAL RESEARCH
- Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines
- (2014) Megan N Breit et al. BMC Veterinary Research
- Laninamivir octanoate
- (2014) C. Reviriego DRUGS OF THE FUTURE
- Su1067 Drug Resistance Mutations in the Ns3 and NS5A Regions in Patients With Hepatitis C Virus Genotype 1b and Response to Telaprevir Plus Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy
- (2014) Kazuhiko Hayashi et al. GASTROENTEROLOGY
- SINE (selective inhibitor of nuclear export) – translational science in a new class of anti-cancer agents
- (2014) John Gerecitano Journal of Hematology & Oncology
- Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
- (2014) Michael P. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nucleotide Oligomerization and Binding Domain 2-Dependent Dendritic Cell Activation Is Necessary for Innate Immunity and Optimal CD8+ T Cell Responses to Influenza A Virus Infection
- (2014) C. Lupfer et al. JOURNAL OF VIROLOGY
- Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo
- (2014) O. Perwitasari et al. JOURNAL OF VIROLOGY
- Mechanisms of RIG-I-Like Receptor Activation and Manipulation by Viral Pathogens
- (2014) M. U. Gack JOURNAL OF VIROLOGY
- Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
- (2014) Jason Haffizulla et al. LANCET INFECTIOUS DISEASES
- At the centre: influenza A virus ribonucleoproteins
- (2014) Amie J. Eisfeld et al. NATURE REVIEWS MICROBIOLOGY
- Progress in the Prevention and Treatment of RSV Infection
- (2014) Peter F. Wright NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study
- (2014) Cheryl A. London et al. PLoS One
- Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors
- (2014) D. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection
- (2014) S. M. Y. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atomic basis of CRM1-cargo recognition, release and inhibition
- (2014) Ho Yee Joyce Fung et al. SEMINARS IN CANCER BIOLOGY
- Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents
- (2014) Joel G. Turner et al. SEMINARS IN CANCER BIOLOGY
- Bat-derived influenza-like viruses H17N10 and H18N11
- (2014) Ying Wu et al. TRENDS IN MICROBIOLOGY
- Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
- (2013) Andrea C Tricco et al. BMC Medicine
- Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial
- (2013) Seizaburo Kashiwagi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Nucleozin Targets Cytoplasmic Trafficking of Viral Ribonucleoprotein-Rab11 Complexes in Influenza A Virus Infection
- (2013) M. J. Amorim et al. JOURNAL OF VIROLOGY
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- IL-1βand IL-6 Upregulation in Children with H1N1 Influenza Virus Infection
- (2013) Antonio Chiaretti et al. MEDIATORS OF INFLAMMATION
- The TLR4 antagonist Eritoran protects mice from lethal influenza infection
- (2013) Kari Ann Shirey et al. NATURE
- Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age
- (2013) C. B. Hall et al. PEDIATRICS
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
- (2013) Zhinan Jin et al. PLoS One
- Type I IFN Triggers RIG-I/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells
- (2013) Julien Pothlichet et al. PLoS Pathogens
- Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease
- (2013) Julie L. McAuley et al. PLoS Pathogens
- Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy Volunteers
- (2012) Hitoshi Ishizuka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance
- (2012) Jennifer L. McKimm-Breschkin Influenza and Other Respiratory Viruses
- A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection
- (2012) R. B. Moss et al. JOURNAL OF INFECTIOUS DISEASES
- The Secreted G Protein of Human Respiratory Syncytial Virus Antagonizes Antibody-Mediated Restriction of Replication Involving Macrophages and Complement
- (2012) A. Bukreyev et al. JOURNAL OF VIROLOGY
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response
- (2012) Margarita K. Lay et al. MICROBES AND INFECTION
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- NESdb: a database of NES-containing CRM1 cargoes
- (2012) Darui Xu et al. MOLECULAR BIOLOGY OF THE CELL
- In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo
- (2012) R. Villenave et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation
- (2012) Kathy Triantafilou et al. THORAX
- Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
- (2012) Gregory M. Glenn et al. VACCINE
- Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2
- (2012) P. Rallabhandi et al. mBio
- Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
- (2011) Eva Kowalinski et al. CELL
- Immunomodulatory therapy for severe influenza
- (2011) Ilyse Darwish et al. Expert Review of Anti-Infective Therapy
- Cholesterol-Rich Microdomains as Docking Platforms for Respiratory Syncytial Virus in Normal Human Bronchial Epithelial Cells
- (2011) H. San-Juan-Vergara et al. JOURNAL OF VIROLOGY
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
- (2011) Farnoosh Tayyari et al. NATURE MEDICINE
- Intensive Cytokine induction in Pandemic H1N1 Influenza Virus Infection Accompanied by Robust Production of IL-10 and IL-6
- (2011) Xuelian Yu et al. PLoS One
- Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration
- (2010) S. Kubo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection
- (2010) Jan Rehwinkel et al. CELL
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Insights into the role of Toll-like receptors in modulation of T cell responses
- (2010) Raveendra Kulkarni et al. CELL AND TISSUE RESEARCH
- Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection
- (2010) Kelvin K. W. To et al. CLINICAL INFECTIOUS DISEASES
- Long‐Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double‐Blind, Randomized, Noninferiority Clinical Trial
- (2010) Akira Watanabe et al. CLINICAL INFECTIOUS DISEASES
- Palivizumab‐Resistant Human Respiratory Syncytial Virus Infection in Infancy
- (2010) Ortwin Adams et al. CLINICAL INFECTIOUS DISEASES
- Azithromycin induces anti-viral responses in bronchial epithelial cells
- (2010) V. Gielen et al. EUROPEAN RESPIRATORY JOURNAL
- High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity
- (2010) C.-Y. Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
- (2010) N. Sigurs et al. THORAX
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Lung Pathology in Fatal Novel Human Influenza A (H1N1) Infection
- (2009) Thais Mauad et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Induction of type I interferon by RNA viruses: cellular receptors and their substrates
- (2009) Alina Baum et al. AMINO ACIDS
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus
- (2009) Thanyada Rungrotmongkol et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The host response and molecular pathogenesis associated with respiratory syncytial virus infection
- (2009) Christine M Oshansky et al. Future Microbiology
- Fighting the Flu with Inflammasome Signaling
- (2009) David M. Owen et al. IMMUNITY
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA
- (2009) Irving C. Allen et al. IMMUNITY
- Respiratory Syncytial Virus Nonstructural Proteins Decrease Levels of Multiple Members of the Cellular Interferon Pathways
- (2009) S. Swedan et al. JOURNAL OF VIROLOGY
- Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
- (2009) W. Zhang et al. JOURNAL OF VIROLOGY
- The Respiratory Syncytial Virus Matrix Protein Possesses a Crm1-Mediated Nuclear Export Mechanism
- (2009) R. Ghildyal et al. JOURNAL OF VIROLOGY
- Structural basis for leucine-rich nuclear export signal recognition by CRM1
- (2009) Xiuhua Dong et al. NATURE
- Activation of innate immune antiviral responses by Nod2
- (2009) Ahmed Sabbah et al. NATURE IMMUNOLOGY
- Structural basis for assembly and disassembly of the CRM1 nuclear export complex
- (2009) Xiuhua Dong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Lipopolysaccharide Induces IL-6 Production in Respiratory Syncytial Virus-Infected Airway Epithelial Cells Through the Toll-Like Receptor 4 Signaling Pathway
- (2009) Xiao-Hong Xie et al. PEDIATRIC RESEARCH
- Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
- (2009) Gallen B. Triana-Baltzer et al. PLoS One
- Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
- (2009) Gallen B. Triana-Baltzer et al. PLoS One
- Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP
- (2009) T. Monecke et al. SCIENCE
- Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway
- (2009) Christine M. Oshansky et al. VIRAL IMMUNOLOGY
- Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008
- (2008) T. G. Sheu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma
- (2008) S. S. Mohapatra et al. CLINICAL MICROBIOLOGY REVIEWS
- Influenza and respiratory syncytial virus in the elderly
- (2008) Alex J Elliot et al. Expert Review of Vaccines
- Towards reconciling structure and function in the nuclear pore complex
- (2008) Roderick Y. H. Lim et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Association of Respiratory Syncytial Virus M Protein with Viral Nucleocapsids Is Mediated by the M2-1 Protein
- (2008) D. Li et al. JOURNAL OF VIROLOGY
- The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes
- (2008) A. Bukreyev et al. JOURNAL OF VIROLOGY
- Structure and mechanism of the M2 proton channel of influenza A virus
- (2008) Jason R. Schnell et al. NATURE
- Pathology of human influenza revisited
- (2008) Thijs Kuiken et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started